Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 8, 2010
Urokinase-targeted fusion by oncolytic Sendai virus eradicates orthotopic glioblastomas by pronounced synergy with interferon-β geneYuzo Hasegawa, Hiroaki Kinoh, Yasuo Iwadate, et al.
Esophagus : Official Journal of the Japan Esophageal Society|July 3, 2022
Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinomaMasaaki Ito, Takaki Hiwasa, Satoshi Yajima, et al.
Diagnostics (Basel, Switzerland)|February 5, 2020
Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep ApneaYusuke Katsumata, Jiro Terada, Takuma Matsumura, et al.
Frontiers in Oncology|September 10, 2021
Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal CancerMasaaki Ito, Takaki Hiwasa, Yoko Oshima, et al.
Medicine International|January 26, 2023
Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney diseaseMasaaki Kubota, Bo-Shi Zhang, Shu-Yang Li, et al.
AACE Clinical Case Reports|July 26, 2021
ICAM1-Negative Intravascular Large B-Cell Lymphoma of the Pituitary Gland: A Case Report and Literature ReviewKumiko Naito, Sawako Suzuki, Chikako Ohwada, et al.
BMC Endocrine Disorders|October 31, 2023
Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitusToshiki Namiki, Minoru Takemoto, Aiko Hayashi, et al.
International Journal of Clinical Oncology|September 29, 2021
Efficacy and safety of nivolumab in Japanese patients with first recurrence of glioblastoma: an open-label, non-comparative studyTomokazu Aoki, Naoki Kagawa, Kazuhiko Sugiyama, et al.
International Journal of Molecular Sciences|May 11, 2024
JMJD6 Autoantibodies as a Potential Biomarker for Inflammation-Related DiseasesBo-Shi Zhang, Xiao-Meng Zhang, Masaaki Ito, et al.
Oncotarget|March 7, 2018
Elevation of autoantibody level against PDCD11 in patients with transient ischemic attackYoichi Yoshida, Hao Wang, Takaki Hiwasa, et al.
Pageof 14